Effect of supplementation in treatment of women with polycystic ovary syndrome

Phase 3

• Conditions: E28.2; Polycystic ovarian syndrome; Polycystic ovary syndrome.

• Registration Number: IRCT201606115623N82
• Lead Sponsor: Vice chancellor for research, Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

Patients with phenotype B of PCOS according to Rotterdam criteria
Aged between18 to 40 years old

Exclusion Criteria

Pregnant women
Women with endocrine diseases including diabetes or impaired glucose tolerance

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Insulin. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.;Total testosterone. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;SHBG. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.;Free testosterone. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.